NLRP3 and Alzheimer disease: In APP/PS1 mice, it attenuated Aβ accumulation, reduced activation of the NLRP3 inflammasome, and lowered pro-inflammatory cytokines such as IL-1β and ROS, underscoring its potential in halting AD-associated neuroinflammation [92].